SETD2 and kidney cancer: A significant reduction in TMEM25 expression was observed among the mutation groups of BAP1, UNC80, EYS, SETD2 and XIRP, compared with the wild group, as BAP1 and SETD2 are commonly occurring mutation types in kidney cancer and have poor prognosis.